CompletedNCT01152697
Adherence Support With Long-Acting Antipsychotic Injections
About this title
Read the official source — NCT01152697Medication studyAges 18+United StatesSchizophrenia
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- ClevelandSee all locations and recruitment
Study information
Study start dateJune 2010
- Recruitment status
- Completed
- Enrollment listed in the registry
- 30
- Sponsor
- University Hospitals Cleveland Medical Center
- Sponsor type
- University
- Study type
- Behavioral
- Intervention type
- Behavioural, Drug
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT01152697
- Official title
Show the full official title
A Prospective Trial of Customized Adherence Enhancement Plus Long-acting Injectable Antipsychotic (CAE-L) in Individuals With Schizophrenia or Schizoaffective Disorder at Risk for Treatment Non-adherence and for Homelessness
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Cleveland
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University Hospitals Cleveland Medical Center, a university.
Did this study involve medication?
Yes. The study involved medication, including haloperidol decanoate and haloperidol.
Who was this study for?
Listed age limits: from 18 years.
